The in vitro activity of ketolide HMR 3647 against coryneform bacteria isolated from clinical samples was evaluated. Except against Corynebacterium jeikeium and C. urealyticum, HMR 3647 showed high activity against Corynebacterium spp., being more active than 14-and 16-membered macrolides, azithromycin, or clindamycin. HMR 3647 also had high in vitro activity against Brevibacterium spp. and Listeria monocytogenes.
, and Brevibacterium spp. (10) . Organisms were identified by conventional phenotypic tests and the API Coryne System, according to Funke et al. (6) . C. amycolatum strains included organisms identified as C. xerosis, C. minutissimum, and CDC coryneform group I2 by the CDC scheme for identification of coryneform bacteria (4). After isolation and identification, bacteria were maintained in 10% glycerol in tryptic soy broth at Ϫ70°C until used. The following reference strains were included: C. jeikeium ATCC 43734, C. urealyticum ATCC 43042, and C. striatum ATCC 6940. Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 were used as control strains.
HMR 3647 (Hoechst-Marion-Roussell, Romainville, France), erythromycin A (Sigma, St. Louis, Mo.), clarithromycin (Abbott Laboratories, Madrid, Spain), roxithromycin (HoechstMarion-Roussell), josamycin (Sigma), azithromycin (Pfizer S.A., Madrid, Spain), and clindamycin (Pharmacia-Upjohn, Kalamazoo, Mich.) were used as powders of known potency. Solutions of antimicrobial agents were prepared on the day of antimicrobial testing, according to the manufacturer's instructions.
A microdilution method was used for susceptibility testing. The guidelines provided by the National Committee for Clinical Laboratory Standards (NCCLS) for dilution susceptibility testing (10) were followed, with some exceptions, as coryneform bacteria are not discussed in this document. Cation-adjusted Mueller-Hinton broth (Difco, Detroit, Mich.) was supplemented with 0.5% Tween 80 in tests of the lypophilic species C. jeikeium and C. urealyticum. Twofold dilutions ranging from 0.03 to 64 g/ml for all antimicrobial agents were tested. The inoculum was prepared from bacterial cultures grown on Columbia agar with 5% sheep blood agar for 20 to 24 h. Bacteria were suspended in Mueller-Hinton broth with (C. jeikeium and C. urealyticum) or without 0.5% Tween 80 to a concentration of about 10 8 CFU/ml and diluted in the same medium to obtain a final concentration of 5 ϫ 10 4 CFU per well. The final volume in each well of the microtiter plate was 100 l. Plates were inoculated and then incubated in air at 35°C for 20 to 22 h or 48 h if no growth was observed at 20 to 22 h or if the organism was C. striatum.
The MICs, MICs at which 50% of the isolates are inhibited (MIC 50 s), and MIC 90 s of the different antimicrobial agents evaluated are shown in Table 1 . The macrolides and clindamycin had low activity against Corynebacterium spp. The ketolide HMR 3647 showed high activity against C. amycolatum, C. striatum, and C. minutissimum but low activity against the more-resistant species C. urealyticum and C. jeikeium. Similar activities of macrolides and clindamycin against Corynebacterium spp. have been reported in other studies (5, 8, 14) , although Soriano et al. (14) reported the MIC 90 s of erythromycin for C. minutissimum strains to be several times higher than those obtained here. It is possible that some of the C. minutissimum strains included in the study of Soriano et al. belong to the newly-recognized C. amycolatum species.
It is important that remarkable differences in the MICs of ketolides and macrolides can be observed for C. striatum if readings are made at 48 h instead of 20 h. At 48 h, all C. striatum strains showed a hazy growth, lower than that observed in control strains or in other coryneforms, in wells containing concentrations of 32 to 64 g/ml. Since the meaning of this residual growth remains unclear, and C. striatum is a nonfastidious bacterium, we chose to establish MICs at 20 h following NCCLS guidelines for nonfastidious microorganisms. This phenomenon could partially explain the higher MICs of HMR 3647 and erythromycin for C. striatum isolates that were obtained by other authors (15) .
At a concentration of 0.5 g/ml, which is the breakpoint of the NCCLS for erythromycin and clindamycin, more than 90% of C. amycolatum, C. striatum, and C. minutissimum strains were inhibited by HMR 3647. These values decreased to 20 and 45% for C. urealyticum and C. jeikeium, respectively. At this concentration, none of the macrolides inhibited more than 20% of Corynebacterium spp., with the exception of C. minutissimum. Forty to 70% of strains of the latter species were inhibited by macrolides at 0.5 g/ml.
The lowest MIC 90 s for L. monocytogenes were those of clarithromycin (0.125 g/ml) and those of HMR 3647 and erythromycin (0.25 g/ml for both antimicrobial agents). At a concentration of 0.5 g/ml, more than 90% of the strains were inhibited by HMR 3647, erythromycin, clarithromycin, and roxithromycin. Josamycin, azithromycin, and clindamycin showed very low activity against this microorganism.
HMR 3647 was the most-active agent against Brevibacterium spp. The MIC 90 of clarithromycin (2 g/ml) was much lower than those of the other macrolides (Ն16 g/ml). 
